Akanksha Verma, DO | |
1 University Of New Mexico, Albuquerque, NM 87131-1501 | |
(281) 250-2486 | |
Not Available |
Full Name | Akanksha Verma |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 1 University Of New Mexico, Albuquerque, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811458128 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | T6067 (Texas) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Akanksha Verma, DO 1 University Of New Mexico, Albuquerque, NM 87131-0001 Ph: (281) 250-2486 | Akanksha Verma, DO 1 University Of New Mexico, Albuquerque, NM 87131-1501 Ph: (281) 250-2486 |
News Archive
Healthcare providers can improve their diagnostic confidence with Toshiba America Medical Systems, Inc.'s more flexible Kalare R&F digital X-ray system. Featuring a new 17" x 17" dynamic flat panel detector (works-in-progress), the system provides clinicians with distortion-free, high-quality images.
Structural brain abnormalities found in patients with bipolar disorder may have been wrongly attributed to the condition and in fact be associated with comorbid attention–deficit hyperactivity disorder, US researchers believe.
Noting that the Global Health Initiative (GHI) leadership and the three core entities of GHI - USAID, the Centers for Disease Control and Prevention (CDC) and PEPFAR - announced the closure of the GHI office and an end to the initiative's current phase on July 3, Serra Sippel, president of the Center for Health and Gender Equity, writes in the Huffington Post's "Politics" blog that "the three agencies will be responsible for ensuring that the GHI principles are implemented in the field to achieve global health goals."
The results of clinical trials have shown one dose of the H1N1 (swine) flu vaccine is enough to offer adults protection against the virus, U.S. and Australian researchers said Thursday, the Associated Press reports (Neergaard, 9/11).
› Verified 7 days ago